Statement for Hearing on “A Prescription for Change: Cracking Down on Anticompetitive Conduct in Prescription Drug Markets”

Everyone should be able to get the medications they need at a cost they can afford. Rising drug prices impose a heavy burden on all Americans— a direct result of high list prices determined solely by drug companies. Too many hardworking Americans must choose between paying their bills and accessing life-saving medicines. AHIP appreciates the Subcommittee’s attention on the problem of drug manufacturers’ anticompetitive conduct in the prescription drug market. We look forward to working with the Subcommittee to advance market-based solutions that reduce drug prices by promoting competition and consumer choice, along with open and honest drug pricing.

Read our statement by clicking the button below.